Yutaka Hatanaka - Concepedia

Author

Yutaka Hatanaka

Also Known As

Emi Takakuwa, Hatanaka, Yutaka, Takahiro Tsuji, Y Hatanaka, Y. Hatanaka, Y., Hatanaka, YUTAKA HATANAKA, Yutaka HATANAKA, Yutaka Hatanaka

235

Publications

3.5K

Citations

H-Index

115

Concepts

All Affiliations

Hokkaido University Hospital Hokkaido University Sapporo Medical University National Cancer Center Hospital East The University of Osaka

About

Yutaka Hatanaka is an author at Hokkaido University Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	39	1.3K
2	Health Sciences	4	4	172
3	Engineering	3	3	91
4	Natural Sciences	2	2	50
5	Biochemistry	2	2	50

Yutaka Hatanaka

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations Christopher P. Wardell, Masashi Fujita, Tōru Yamada, Journal of Hepatology	2018	361
Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers Eiichi Sasaki, Nobuyuki Tsunoda, Yutaka Hatanaka, Modern Pathology Tumor BiologyBreast OncologyVarious OrgansMedicinePathology	2006	135
Disruption of the blood brain barrier by brain metastases of triple‐negative and basal‐type breast cancer but not <i>HER2/neu</i>‐positive breast cancer Kan Yonemori, Koji Tsuta, Makiko Ono, Cancer	2009	128
Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer Tatsuya Yoshioka, Mitsuchika Hosoda, Mitsugu Yamamoto, Breast Cancer Breast OncologyMedicinePathologyBreast CancerCancer Treatment	2013	103
Cytometrical image analysis for immunohistochemical hormone receptor status in breast carcinomas Yutaka Hatanaka, Kaoru Hashizume, Kazuo Nitta, Pathology International Breast OncologyPathologyGynecologyImage Analysis MethodTumor Biology	2003	80
p53 accumulation is a strong predictor of recurrence in estrogen receptor‐positive breast cancer patients treated with aromatase inhibitors Mitsugu Yamamoto, Mitsuchika Hosoda, Kiichiroh Nakano, Cancer Science Endocrine OncologyBreast OncologyMedicineP53 AccumulationStrong Predictor	2013	76
Fatty acid‐binding protein 5 function in hepatocellular carcinoma through induction of epithelial–mesenchymal transition Takanori Ohata, Hideki Yokoo, Toshiya Kamiyama, Cancer Medicine	2017	73
Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray Takeo Nitta, Tomoko Mitsuhashi, Yutaka Hatanaka, British Journal of Cancer	2014	67
Quantitative immunohistochemical evaluation of HER2/<i>neu</i> expression with HercepTest<sup>TM</sup> in breast carcinoma by image analysis Yutaka Hatanaka, Kaoru Hashizume, Yuki Kamihara, Pathology International	2001	59
CC‐chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor‐infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma Naoko Kanagawa, Masakazu Niwa, Yutaka Hatanaka, International Journal of Cancer	2007	59

Page 1